Positron Emission Tomography (PET) News and Research

RSS

Researchers use brain connectome to reassess neuroimaging findings of Alzheimer's disease

Already affecting more than five million Americans older than 65, Alzheimer's disease is on the rise and expected to impact more than 13 million people by 2050.

17 Dec 2018

Ritalin drug affects organization of pathways that build brain networks used in attention, learning

There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.

13 Dec 2018

Using molecular targeting approach to kill melanoma cells

In 1960, scientists described the "Philadelphia chromosome" that causes chronic myeloid leukemia, and in 2001 the Food and Drug Administration approved the drug imatinib to disable the action of this cancer-causing genetic change.

27 Nov 2018

World's first medical imaging scanner produces diagnostic scan of the whole human body

EXPLORER, the world's first medical imaging scanner that can capture a 3-D picture of the whole human body at once, has produced its first scans.

20 Nov 2018

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai Co., Ltd. announced that Biogen presented results at the Clinical Trials on Alzheimer's Disease meeting, in Barcelona, Spain, from the recent 36- and 48-month analyses of the ongoing long-term extension of the Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD.

29 Oct 2018

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai Co., Ltd. announced results from a recent analysis of the ongoing long-term extension Phase 1b study of aducanumab, an investigational treatment for mild cognitive impairment due to Alzheimer's disease and mild AD dementia.

24 Sep 2018

Novel decoding technology could predict mood variations from brain signals

By developing a novel decoding technology, a team of engineers and physicians at the University of Southern California and UC San Francisco have discovered how mood variations can be decoded from neural signals in the human brain--a process that has not been demonstrated to date.

10 Sep 2018

Major pitfall identified in popular prostate cancer PET imaging method

Prostate-specific membrane antigen positron emission tomography imaging has become a popular method for determining the stage of a patient's prostate cancer.

7 Sep 2018

New nuclear medicine imaging method could help diagnose widespread tumors

A new nuclear medicine imaging method could help diagnose widespread tumors, such as breast, colon, pancreas, lung and head and neck cancer better than current methods, with less inconvenience to patients and with equal or improved accuracy.

6 Sep 2018

Research shows new way to target drug delivery for brain tumors

A person's brainstem controls some of the body's most important functions, including heart beat, respiration, blood pressure and swallowing. Tumor growth in this part of the brain is therefore twice as devastating.

5 Sep 2018

Study shows link between thinning of the retina and early sign of Parkinson's disease

The eyes may be a window to the brain for people with early Parkinson's disease. People with the disease gradually lose brain cells that produce dopamine, a substance that helps control movement.

16 Aug 2018

Researchers use PET tracer to identify ER expression differences in metastatic breast cancer patients

In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor expression of the metastases.

7 Aug 2018

New nuclear medicine test could improve care of patients with type 1 diabetes

Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The new positron emission tomography imaging method could measure beta-cell mass, which would greatly enhance the ability to monitor and guide diabetes therapies.

3 Aug 2018

New biosensor could enable early non-invasive diagnosis of Alzheimer's disease through magnetic resonance imaging

UPM researchers are involved in the development of a new biosensor that can be useful to achieve an early non-invasive diagnosis of Alzheimer's disease using magnetic resonance imaging.

12 Jul 2018

Study finds disrupted stress response in people with schizophrenia

Stressful situations affect the brain and body differently in people with schizophrenia compared to people without the mental illness or individuals at high risk for developing psychosis, a new CAMH study shows.

11 Jul 2018

Researchers develop personalized 'Therapeutic Intervention Fingerprint'

Personalized medicine - delivering therapies specially tailored to a patient's unique physiology - has been a goal of researchers and doctors for a long time.

11 Jul 2018

New TSPO-targeted PET imaging more fully evaluates extent of rheumatoid arthritis

A new positron emission tomography imaging method more fully evaluates the extent of rheumatoid arthritis by targeting translocator protein expression in the synovium (joint lining tissue).

10 Jul 2018

Finnish researchers gain new insights on brain activity during general anesthesia

Finnish researchers have gained new information on brain activity during general anesthesia by recording changes in the electrical activity of the brain.

3 Jul 2018

Novel theranostic agent designed for precise tumor diagnosis and therapy

A novel, intelligent theranostic agent for precise tumor diagnosis and therapy has been developed that remains as small molecules while circulating in the bloodstream, can then self-assemble into larger nanostructures in the tumor, and be activated by the tumor microenvironment for therapy guided by photoacoustic imaging.

26 Jun 2018

New molecular imaging method could help effectively tackle brain conditions

A new molecular imaging method can monitor the success of gene therapy in all areas of the brain, potentially allowing physicians to more effectively tackle brain conditions such as Parkinson's disease, Alzheimer's disease and multiple sclerosis.